Boothbay Fund Management, LLC Agenus Inc Transaction History

Boothbay Fund Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $14,574 - $26,372	23,134 New	23,134 $19,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $30,265 - $61,461	-23,281 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $30,493 - $45,026	12,976 Added 125.92%	23,281 $57,000
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $128,006 - $251,630	-43,838 Reduced 80.97%	10,305 $33,000
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $19,616 - $26,115	3,939 Added 7.85%	54,143 $284,000
Q2 2021 Aug 16, 2021	SELL	$2.56 - $5.49 $140,403 - $301,099	-54,845 Reduced 52.21%	50,204 $276,000
Q1 2021 May 17, 2021	SELL	$2.69 - $5.25 $30,130 - $58,805	-11,201 Reduced 9.64%	105,049 $286,000
Q4 2020 Feb 12, 2021	BUY	$3.17 - $4.49 $50,802 - $71,956	16,026 Added 15.99%	116,250 $370,000
Q3 2020 Nov 16, 2020	BUY	$2.98 - $5.2 $298,667 - $521,164	100,224 New	100,224 $401,000
Q1 2019 May 15, 2019	SELL	$2.51 - $3.73 $165,554 - $246,023	-65,958 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.59 - $2.66 $104,873 - $175,448	65,958 New	65,958 $157,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.